Clinical Trials Browser

Phase 1/2 × Carcinoma × avelumab × Clear all

NCT04261855 2026-03-27

GoTHAM

Phase 1/2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT03268057 2022-05-02

CLASSICAL-Lung

Phase 1/2 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung